1 / 17

Ciprofloxacin: Antibiotic for the Treatment of Anthrax

Ciprofloxacin: Antibiotic for the Treatment of Anthrax. Anne Malhowski and Erin Murphy CHM 357 10.27.04. Anthrax. Disease caused by Bacillus anthracis, a gram-positive spore-forming bacteria anthrax spores are found in the soil

niveditha
Download Presentation

Ciprofloxacin: Antibiotic for the Treatment of Anthrax

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ciprofloxacin: Antibiotic for the Treatment of Anthrax Anne Malhowski and Erin Murphy CHM 357 10.27.04

  2. Anthrax • Disease caused by Bacillus anthracis, a gram-positive spore-forming bacteria • anthrax spores are found in the soil • Spores have no smell, taste, or color and are too small to be seen by eye • need an environment that is rich in amino acids, nucleosides and glucose to germinate • Once the germination begins, the disease progresses very rapidly • The anthrax disease is not contagious

  3. How is anthrax spread? • Inhalation - spores can be inhaled in contaminated soil. • cutaneous (skin) - spread by biting insects that have fed on infected hosts (95% of anthrax cases) • gastrointestinal–caused by ingesting undercooked meat or unchlorinated water that harbors anthrax bacteria

  4. Anthrax in a host… • bacteria attacks the lymph nodes • three proteins are created by the bacteria: protective antigen (PA) edema factor (EF) lethal factor (LF) • the lethal factor cuts mitogen-activated protein kinase, an enzyme that controls cell growth and is involved in cellular signal transmission • disrupting signal transmission results in anthrax symptoms

  5. Symptoms of Anthrax Inhalation– occurs in two stages that surface in approximately 7-10 days • Stage 1 - begins with fever, cough, headache, vomiting, chills, weakness, abdominal pain, shortness of breath and chest pain. (hours-several days) • Stage 2 - fever, difficulty breathing, sweating, a bluish discoloration of the skin, shock, and finally death (2-4days) Cutaneous– occurs within 12 days of exposure • localized swelling of the skin, which enlarges into an ulcer and discharges a clear fluid. Then, a black scab will form that falls off in one to two weeks. Gastrointestinal– occurs within several days • symptoms include nausea, vomiting blood, abdominal pain, bloody diarrhea, and weakness • Results in death for 25 to 60 percent of cases

  6. Anthrax Life Cycle http://www.ph.ucla.edu/epi/bioter/anthraxlifecycle.html

  7. Diagnosis and Treatment Diagnosis through Gram-staining: • A blood sample is cultured and then gram-stained to identify the genus level (Bacillus family) • Cutaneous - vesicular fluid and bloodInhalation - blood, cerebrospinal fluid, or chest X-rayGastrointestinal - blood Treatment: • Anthrax can be treated with the antibiotics, penicillin, doxycylcine, or ciprofloxacin. • If inhalation anthrax is not caught soon, then the bacteria would be destroyed but the toxins would remain in the system, killing the host. *Gram-stained anthrax

  8. Fatality Statistics of Anthrax • Cutaneous – 20% • Inhalation – 75% • Gastrointestinal - 25%-60% *Statistics according to the Center for Disease Control (CDC)

  9. Anthrax as a Biological Weapon • LD = one millionth of a gram • LD50 = 2,500 to 55,000 inhaled anthrax spores • If 100 kg of anthrax spores were released into Washington, DC, 130,000 to 3 million would die. • \ http://www.brown.edu/Courses/Bio_160/Projects2000/Anthrax/epidemiology/infection_statistics.html http://images.usatoday.com/news/gallery/terr1015/anthrax.jpg

  10. Antibiotic • Antibiotic • Destroys bacterial cells without harming human cells • Takes advantage of the differing enzymatic make up of the two

  11. Cipro (Ciprofloxacin) • Cipro • Antibiotic effective treatment against Anthrax bacteria • Also used in the treatment of UTIs and Pyelonephritis • Kidney infection caused by food borne illness E. Coli • Treats bacterial infections from bronchitis to gonorrhea • Antimicrobial HIV/AIDS medication

  12. Drug Classification • Quinolones: antimicrobial agent • Most have excellent bioavailability • Adverse effects: nausea, headache, dizziness, and confusion • Rapidly inhibit DNA synthesis by promoting bacterial DNA cleavage in the enzyme components of DNA gyrase and type IV topoisomerase • Resulting in rapid bacterial death • Exhibit concentration-dependant bacterial killing • Well absorbed following oral administration • Drug must be administered every 12 to 24hrs because elimination half-lives range from 1.5 to 16hrs.

  13. Mechanism of Action • Inhibits bacterial nuclear DNA synthesis • Rapid death of bacteria • Target sight for Cipro is the enzyme DNA gyrase (topoismomerase II) • Responsible for the supercoiling and uncoiling of the DNA • Supercoiling: allows long DNA to fit into a cell • Uncoiling: required for replication, transcription, and DNA repair • Cipro prevents bacterial DNA from creating enzymes and reproducing

  14. Pharmacokinetics/Chemistry • Absorbed from the gastrointestinal tract after oral administration • The unrestricted bioavailability is ~70% with no significant loss by first pass metabolism • Elimination half-life is approximately 4hrs • Urinary excretion of Cipro complete in 24hrs • Cipro I.V (C17H18FN3O3) MW: 331.4 • Cipro XR (C17H18FN3O3 HCl H2O) MW:385.8

  15. Structure of Cipro • Cipro XR • Quinolone

  16. Side Effects • Gastrointestinal intolerance • Nausea, vomiting, diarrhea • Photosensitivity • Occasionally CNS toxicity • Dizziness and tremors

  17. FDA approval • Approved on July 28th, 2000 • Approved for post-exposure to inhalation anthrax • Approved under accelerated approval regulations

More Related